Alternatives to Oak

A newer (2024) compounding desk whose real hook is form: it runs an oral/sublingual line alongside the usual injections, on both molecules, with no membership tacked on.

Sema

$249/mo sublingual · $297/mo injectable

Coverage

Not publicly listed

▬price stable

FDA warning letter, September 2025 — issued to directmeds.com, Inc. dba DirectMeds. See the FDA's warning letter database.

Publishes a price for every dose of every route — which makes it easy to brief, and expensive if you stay low.

Sema

$239/mo injectable · $219/mo sublingual (quarterly)

Coverage

40 states

▬price stable

An all-in, LegitScript-verified GLP-1 line with a simple sticker price — billed every 4 weeks rather than by the calendar month, and with no named prescriber or pharmacy behind it.

Sema

$249/mo injectable · $279/mo oral (billed per 4 weeks)

Coverage

All 50 states + DC

◆new to the tracker, no prior reading

A six-shelf prescription telehealth catalog whose GLP-1 price genuinely holds flat as you titrate — but whose every advertised figure is a twelve-month prepay rate, with the month-to-month price published nowhere.

Sema

$259/mo (month-to-month; prepay tiers lower)

Coverage

44 states (not KS, LA, MS, NM, ND, WV)

◆new to the tracker, no prior reading

REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

Sema

$219/mo (all doses, compounded)

Coverage

All 50 states

◆new to the tracker, no prior reading

RedBox Rx is a US telehealth pharmacy (parent company Hy-Vee) offering compounded GLP-1 weight management with flat, dose-independent pricing.

Sema

From $269/mo (all doses, 6-month plan, compounded)

Coverage

Coverage not published

◆new to the tracker, no prior reading

Fitish offers compounded semaglutide ($219/28 days) and compounded tirzepatide ($339/28 days) including consultation and shipping.

Sema

From $219/mo (compounded)

Coverage

All 50 states

◆new to the tracker, no prior reading

FDA warning letter, June 2026 — issued to FITISH. See the FDA's warning letter database.

Tell Her Doc is a women-focused, self-pay telehealth program for compounded GLP-1 weight loss — compounded semaglutide and tirzepatide in injection, oral, and orally-dissolving-tablet forms, plus microdoses.

Sema

From $269/mo (microdose tier, plus a separate fee, compounded)

Coverage

All 50 states

◆new to the tracker, no prior reading